25572 Impact of risankizumab on the duration of PASI90 achievement: A post hoc analysis of 4 phase III clinical trials

Saved in:
Bibliographic Details
Published inJournal of the American Academy of Dermatology Vol. 85; no. 3; p. AB62
Main Authors Lebwohl, Mark G., Soliman, Ahmed M., Yang, Hongbo, Wang, Jessie, Koenigsberg, Sarah H., Anderson, Annika, Padilla, Bryon, Pinter, Andreas
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.09.2021
Online AccessGet full text

Cover

More Information
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2021.06.274